Key Details
Annual EPS
-$0.96Annual ROE
-169.38%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 04, 2022Recent annual earnings:
Mar 23, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
07 Mar '23 HC Wainwright & Co.
Neutral01 Mar '23 SVB Leerink
Market Perform26 Aug '22 HC Wainwright & Co.
Buy16 Aug '22 Truist Securities
Hold16 Aug '22 Cowen & Co.
Market Perform15 Aug '22 BMO Capital
Outperform12 Aug '22 Piper Sandler
Neutral05 Aug '22 SVB Leerink
Outperform19 May '22 Piper Sandler
Overweight21 Apr '22 SVB Leerink
OutperformScreeners with APTX included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Aptinyx doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Here's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock Now
APTX
Zacks Investment Research30 March 2023
After losing some value lately, a hammer chart pattern has been formed for Aptinyx Inc. (APTX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
FAQ
- What is the primary business of Aptinyx?
- What is the ticker symbol for Aptinyx?
- Does Aptinyx pay dividends?
- What sector is Aptinyx in?
- What industry is Aptinyx in?
- What country is Aptinyx based in?
- When did Aptinyx go public?
- Is Aptinyx in the S&P 500?
- Is Aptinyx in the NASDAQ 100?
- Is Aptinyx in the Dow Jones?
- When was Aptinyx's last earnings report?
- When does Aptinyx report earnings?
- Should I buy Aptinyx stock now?
What is the primary business of Aptinyx?
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
What is the ticker symbol for Aptinyx?
The ticker symbol for Aptinyx is NASDAQ:APTX
Does Aptinyx pay dividends?
No, Aptinyx does not pay dividends
What sector is Aptinyx in?
Aptinyx is in the Healthcare sector
What industry is Aptinyx in?
Aptinyx is in the Biotechnology industry
What country is Aptinyx based in?
Aptinyx is headquartered in United States
When did Aptinyx go public?
Aptinyx's initial public offering (IPO) was on 21 June 2018
Is Aptinyx in the S&P 500?
No, Aptinyx is not included in the S&P 500 index
Is Aptinyx in the NASDAQ 100?
No, Aptinyx is not included in the NASDAQ 100 index
Is Aptinyx in the Dow Jones?
No, Aptinyx is not included in the Dow Jones index
When was Aptinyx's last earnings report?
Aptinyx's most recent earnings report was on 4 August 2022
When does Aptinyx report earnings?
The date for Aptinyx's next earnings report has not been announced yet
Should I buy Aptinyx stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions